Congratulations to Kintor Pharmaceutical Ltd. (stock code: 9939.HK) on its successful listing on the main board of HKSE on 22 May 2020. With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services relating to equity financing, equity incentive plan, intangible assets impairment test and acquisitions.
Date: 22 May 2020 | Tags: Business Valuation, Initial Public Offering (IPO)